BioRestorative Therapies, Inc. short interest in 2022
In 2022, BioRestorative Therapies, Inc.'s disclosed short interest ran from 2.12% of shares outstanding on 31 Mar 2022 to 1.31% on 30 Dec 2022, a change of -0.81 percentage points. The year's high was 2.29% on 14 Apr 2022 and its low 1.22% on 30 Jun 2022, averaging 1.51% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.37 days on 15 Nov 2022. Full history: BioRestorative Therapies, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 2.12% (31 Mar 2022)
- End of year
- 1.31% (30 Dec 2022)
- Change
- -0.81 pp
- High
- 2.29% (14 Apr 2022)
- Low
- 1.22% (30 Jun 2022)
- Average
- 1.51%
- Highest days to cover
- 9.37 (15 Nov 2022)
- SEC filings marked
- 4
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Mar 2022 | 2.12% | 2.17 | 10-K filed |
| 14 Apr 2022 | 2.29% | 1.30 | |
| 29 Apr 2022 | 2.17% | 5.14 | |
| 13 May 2022 | 1.63% | 2.23 | |
| 31 May 2022 | 1.26% | 4.00 | 10-Q filed |
| 15 Jun 2022 | 1.43% | 3.44 | |
| 30 Jun 2022 | 1.22% | 2.10 | |
| 15 Jul 2022 | 1.29% | 3.10 | |
| 29 Jul 2022 | 1.25% | 4.14 | |
| 15 Aug 2022 | 1.37% | 2.59 | 10-Q filed |
| 31 Aug 2022 | 1.39% | 3.54 | |
| 15 Sep 2022 | 1.32% | 5.67 | |
| 30 Sep 2022 | 1.56% | 2.17 | |
| 14 Oct 2022 | 1.66% | 7.75 | |
| 31 Oct 2022 | 1.32% | 7.68 | |
| 15 Nov 2022 | 1.30% | 9.37 | 10-Q filed |
| 30 Nov 2022 | 1.37% | 7.77 | |
| 15 Dec 2022 | 1.47% | 1.20 | |
| 30 Dec 2022 | 1.31% | 4.94 |
See also: BioRestorative Therapies, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.